Posts

Showing posts with the label Esophageal Cancer market outlook

Esophageal Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Esophageal cancer is the seventh leading cause of death in males in the United States (US). Squamous cell carcinoma is the most common histology for EC worldwide; however, adenocarcinoma is the most predominant histology in the US. Early-stage EC may be totally asymptomatic or may present with mild nonspecific symptoms such as heartburn, atypical chest pain, or dyspepsia. Alternatively, patients may present with symptoms such as occult blood in the stool or iron deficiency anemia. Patients may report mild or intermittent dysphagia, odynophagia, or a foreign body sensation. These symptoms generally warrant diagnostic evaluation, including an esophagogastroduodenoscopy (EGD) (upper endoscopy), including a diagnostic mucosal biopsy. Some early cancers are diagnosed during routine upper endoscopic surveillance of Barrett’s esophagus. The symptoms of EC generally progress rapidly. ·        The overall incidence of esophageal cancer (EC) ranges between 4....

Esophageal Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
 Esophageal cancer is the seventh leading cause of death in males in the United States (US). Squamous cell carcinoma is the most common histology for esophageal cancer worldwide; however, in the US, adenocarcinoma is the most predominant histology. Early-stage esophageal cancer may be totally asymptomatic or may present with mild nonspecific symptoms such as heartburn, atypical chest pain, or dyspepsia. Alternatively, patients may present with symptoms such as occult blood in the stool or iron deficiency anemia. Patients may report mild or intermittent dysphagia, odynophagia, or a foreign body sensation. These symptoms generally warrant the diagnostic evaluation, including an esophagogastroduodenoscopy (EGD) (upper endoscopy) including a diagnostic mucosal biopsy. Some early cancers are diagnosed during routine upper endoscopic surveillance for Barrett’s esophagus. The symptoms of esophageal cancer generally progress rapidly. ·        The overall inc...